Edward M. Kaye M.D., Director at Stoke Therapeutics, Inc. (STOK), sold 38,578 shares at $8.27 ($327K) on 2025-03-19, disclosed to the SEC on 2025-03-20.
Open-market sale of $327k STOK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.67 | 10,382 | $90K | 27.5% |
| 2 | $8.67 | 10,382 | $90K | 27.5% |
| 3 | $8.27 | 8,907 | $74K | 22.5% |
| 4 | $8.27 | 8,907 | $74K | 22.5% |
| Total | $8.49 avg | 38,578 | $327K | 100% |
| Filing → |
| STOK | SELL | 2025-12-10 | $702K | — | Filing → |
| STOK | SELL | 2025-12-05 | $879K | — | Filing → |
| STOK | SELL | 2025-12-03 | $65K | — | Filing → |